₹392.25
0.6 (0.2%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 384.81 | Bullish |
| 10-DMA | 379.93 | Bullish |
| 20-DMA | 372.71 | Bullish |
| 50-DMA | 324.34 | Bullish |
| 100-DMA | 285.57 | Bullish |
| 200-DMA | 268.17 | Bullish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 2,155 | 1,753 | 1,913 | 2,251 | 1,757 |
| Total Expenditure | 1,713 | 1,294 | 1,485 | 1,631 | 1,278 |
| Other Income | 154 | 156 | 118 | 72 | 32 |
| Operating Profit | 596 | 615 | 545 | 692 | 511 |
| Interest | 1 | 2 | --- | 1 | 1 |
| Depreciation | 32 | 26 | 23 | 16 | 10 |
| Profit Before Tax | 665 | 587 | 522 | 690 | 500 |
| Consolidated Net Profit | 544 | 452 | 416 | 511 | 376 |
| Adjusted EPS | 17 | 14 | 13 | 16 | 12 |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 32 | 32 | 32 | 32 | 32 |
| Total Reserves | 3,834 | 3,322 | 2,902 | 2,518 | 2,039 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 27 | 35 | 26 | 27 | 17 |
| Other Current Liabilities | 104 | 88 | 82 | 101 | 60 |
| Short Term Borrowings | --- | --- | --- | --- | --- |
| Total Liabilities | 4,049 | 3,567 | 3,113 | 2,753 | 2,216 |
| Capital Work in Progress | 11 | 11 | 11 | 12 | 11 |
| Long Term Loans & Advances | 167 | 648 | 63 | 61 | 81 |
| Currents Investments | 1,977 | 452 | 391 | 55 | 32 |
| Short Term Loans and Advances | 611 | 288 | 9 | 4 | 15 |
| Total Current Assets | 3,245 | 1,544 | 2,013 | 1,683 | 1,214 |
| Total Assets | 4,049 | 3,567 | 3,113 | 2,753 | 2,216 |
| Adjusted Book Value | 120 | 105 | 91 | 79 | 65 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters